At a glance
- Originator Aventis
- Class Antihypertensives
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 27 Jun 2000 Discontinued for Hypertension in USA (unspecified route)
- 27 Jun 1995 No-Development-Reported for Hypertension in USA (Unknown route)